• Heparin Sodium at the HSPG–Nanovesicle Interface

  2026-08-14

  Heparin sodium is more than a glycosaminoglycan anticoagulant: its structural relationship to heparan sulfate creates a useful hypothesis-testing tool for nanovesicle uptake studies. This article connects coagulation assay discipline with the HSPG-dependent Sertoli-cell findings reported for Cistanche deserticola nanovesicles.

• Lenalidomide and DOT1L: Reprogramming Myeloma Immunity

  2026-08-14

  Lenalidomide is more than a conventional immunomodulatory drug: emerging evidence shows that epigenetic control of innate immune signaling may determine its activity in multiple myeloma. This translational guide connects CC-5013 pharmacology with DOT1L-dependent interferon responses, assay design, and a practical strategy for testing mechanistic combination hypotheses.

• 3X (DYKDDDDK) Peptide Workflow Guide

  2026-08-13

  Build cleaner FLAG-based capture, elution, and detection workflows with a hydrophilic trimeric epitope reagent designed for strong antibody recognition. This guide connects routine affinity purification to interactome analysis, metal-sensitive ELISA optimization, and protein crystallization with FLAG tag while emphasizing controls and troubleshooting.

• Stat3 in Fyn-Driven Dopaminergic Neurodegeneration

  2026-08-13

  A 2024 Disease Models & Mechanisms study developed a neural-specific zebrafish model of constitutively active Fyn kinase and linked dopaminergic neuron loss with microglial inflammation. Live imaging, transcriptomics, and pathway inhibition identify Stat3 as a downstream Fyn effector that cooperates with NF-κB, providing a mechanistic framework for studying kinase-associated neurodegeneration.

• Simvastatin (Zocor) Cell Assay Workflows

  2026-08-12

  Simvastatin (Zocor) supports controlled studies of cholesterol biosynthesis, hepatic cancer phenotypes, and cell-line-specific drug responses. This workflow combines solvent discipline, orthogonal validation, and high-content imaging so researchers can distinguish genuine HMG-CoA reductase biology from precipitation, toxicity, or morphology-driven artifacts.

• Berberine Hydrochloride: Reliable Cell Assays

  2026-08-12

  Learn how Berberine Hydrochloride (SKU N1368) can improve the interpretation and reproducibility of cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solubility, assay compatibility, mechanistic controls, and practical vendor-selection criteria.

• Epicardial Fat-Neural Axis in Cardiac Arrhythmia

  2026-08-11

  Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin-NPY-Y1R pathway. The study connects this signaling route to NCX and CaMKII activity, while patient observations support its relevance to atrial fibrillation and suggest experimentally testable intervention points.

• Bestatin Stimulates Endothelial Invasion in Fibrin

  2026-08-11

  The 2003 study by van Hensbergen and colleagues revealed that bestatin, widely investigated as an anti-angiogenic aminopeptidase inhibitor, instead enhanced microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. Its dose-dependent response, together with results from CD13-blocking antibodies and other aminopeptidase inhibitors, suggests that non-CD13 aminopeptidases may regulate angiogenic behavior in fibrin-rich environments.

• AMPK Suppresses Autophagy During Energy Stress

  2026-08-10

  The reference study challenges the prevailing view that AMPK universally activates autophagy during glucose shortage. Its experiments show that AMPK suppresses ULK1–Atg14–Vps34 signaling during severe energy stress while protecting autophagy machinery from caspase-mediated degradation, thereby preserving the capacity for recovery.

• Ranolazine: An Assay-Design Guide

  2026-08-09

  Ranolazine is an anti-ischemic agent whose late sodium current inhibition and metabolic actions can be separated through mechanism-aware assay design. This guide connects cardiac ischemia research with carefully bounded liver and HBV pathway studies without overstating evidence.

• Clodronate Liposomes: In Vivo Macrophage Depletion

  2026-08-08

  Clodronate Liposomes deliver liposome-encapsulated clodronate to phagocytic macrophages for controlled in vivo macrophage depletion. The reagent supports several administration routes, includes a PBS liposome control option, and provides a practical perturbation framework for studying tumor-associated macrophages and immune cell modulation.

• Gefitinib in Patient-Derived Gastric Assembloids

  2026-08-07

  Gefitinib (ZD1839) provides a defined EGFR perturbation for testing how matched stromal cells reshape drug response in patient-derived gastric cancer assembloids. This workflow pairs pathway-level biomarkers with viability, cell-cycle, and apoptosis readouts to distinguish true resistance from model-specific assay effects.

• SB743921: Kinesin Spindle Protein Inhibitor Transforms Cance

  2026-08-07

  SB743921 empowers cancer researchers with precise, reproducible cell cycle arrest and apoptosis induction in both in vitro and xenograft models. Its nanomolar potency and selectivity elevate drug response analysis, while workflow flexibility and troubleshooting insights maximize the value of every experiment.

• Necrosulfonamide (NSA): Selective MLKL Inhibitor for Necropt

  2026-08-06

  Necrosulfonamide (NSA) is a potent and selective inhibitor of MLKL, the terminal effector in the necroptosis pathway, with high specificity and nanomolar efficacy. NSA preserves membrane integrity by blocking MLKL translocation, and is widely used in cell death pathway research and disease models involving necroptosis. Its mechanism, applications, and workflow integration are benchmarked by peer-reviewed studies and APExBIO product data.

• Ciprofloxacin in Research: Protocols, Applications & Innovat

  2026-08-06

  Ciprofloxacin stands apart as a research-grade fluoroquinolone antibiotic, bringing precision to antimicrobial resistance studies and next-generation nanomedicine workflows. This article details actionable protocols, experimental enhancements, and troubleshooting strategies to maximize its impact in advanced laboratory settings.

16409 records 1/1094 page Next 12345 下5页 Last page